Back to top
more

Better trading starts here.

Brokerage Reports

Research for MRNA

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

4 items in cart

View Cart/Checkout

Moderna, Inc. [MRNA]

Reports for Purchase

Showing records 241 - 258 ( 258 total )

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 241

01/24/2020

Industry Report

Pages: 2

Healthcare - Yas'' Weekly Recap of Our Key Notes and 9 Doc Calls Upcoming in 1Q20

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 10.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 242

01/21/2020

Daily Note

Pages: 6

Focusing on the Winner''s in 2020

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 243

01/21/2020

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 244

01/11/2020

Industry Report

Pages: 3

Healthcare- Yas'' Weekly Recap of Our Key Notes and Upcoming Events

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 10.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 245

01/10/2020

Company Report

Pages: 11

CMV Cashes In 2020

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 246

01/10/2020

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 247

12/27/2019

Industry Report

Pages: 3

Yas'' Weekly Recap of Our Key Notes

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 10.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 248

12/27/2019

Industry Report

Pages: 6

Part 2: "Must-See" Companies at JPM (Mkt. Cap. $100M-$499M) With 1Q20 Catalysts

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 249

12/26/2019

Industry Report

Pages: 10

As we are three weeks away from JPM Healthcare conference.

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 250

12/13/2019

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 251

12/13/2019

Industry Report

Pages: 2

Yas'' Weekly Recap of Our Key Notes and Upcoming Events

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 10.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 252

12/12/2019

Company Report

Pages: 8

RNA Medicine Is a Hot Commodity

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 253

12/05/2019

Industry Report

Pages: 9

Keeping up with LNP Delivery: Must Read Takeaways from Our Call with Dr.Cullis

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 25.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 254

11/08/2019

Daily Note

Pages: 2

Healthcare - Earnings Recap: Halftime Show of Our Most In-Depth, Differentiated Earnings Yet

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 10.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 255

11/07/2019

Company Report

Pages: 13

3Q19 - Steps On the Gas with Eyes Fixed on CMV - Chikungunya

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 50.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 256

11/07/2019

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 257

10/25/2019

Company Report

Pages: 239

We initiate coverage with a Buy rating and $24/share price target

Provider: Roth Capital Partners, Inc.

Analyst: RAHIMI Y

Price: 150.00

Research Provided by a Third Party

Company: Moderna, Inc.

Industry: Medical - Biomedical and Genetics

Record: 258

10/25/2019

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party